Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department

被引:56
作者
Carpio, Ricardo [1 ,2 ]
Zapata, Juan [1 ]
Spanuth, Eberhard [3 ]
Hess, Georg [4 ]
机构
[1] Hosp Nacl Edgardo Rebagliati Martins EsSalud, Lima, Peru
[2] Univ Peruana Ciencias Aplicadas, Sch Med, Lima, Peru
[3] DIAneering Diagnost Engn & Res, Heidelberg, Germany
[4] Johannes Gutenberg Univ Mainz, Dept Internal Med, Mainz, Germany
关键词
Presepsin; Emergency department; Sepsis; Diagnosis; Prognosis; Outcome prediction; SOLUBLE CD14 SUBTYPE; PREDICTION; MORTALITY; PROCALCITONIN; BIOMARKERS; MANAGEMENT;
D O I
10.1016/j.cca.2015.08.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Presepsin (PSEP) is released during infectious diseases and can be detected in the blood. PSEP has shown promising results as sepsis marker. We examined the diagnostic and prognostic validity of PSEP in patients suspicious of sepsis on admission in the emergency department (ED). Methods: One hundred twenty three patients with signs of SIRS and/or sepsis and 123 healthy individuals were enrolled. PSEP was determined on admission, after 8, 24 and 72 h. Results: Mean PSEP concentrations of the control group and the patient group were 130 and 1945 pg/ml. PSEP differed between SIRS, sepsis, severe sepsis and septic shock and showed strong association with 30-day mortality ranging from 103% in the 1st to 32.1% in the 4th quartile. The ROC curve analyses revealed an AUC value of 0.743. Combined assessment of PSEP and MEDS score increased the AUC up to 0.878 demonstrating the close relationship with outcome. Based on the PSEP values in the different severity degrees, decision thresholds for risk stratification were established. The course of PSEP during the first 72 h was associated with effectiveness of treatment and outcome. Conclusions: PSEP allowed outcome prediction already on admission to a similar degree as the clinical scores MEDS and APACHE II. Combination of PSEP with MEDS score improved the discriminatory power for outcome prediction. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 23 条
[1]  
[Anonymous], CRIT CARE MED
[2]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[3]   Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department [J].
de Guadiana Romualdo, Luis Garcia ;
Esteban Torrella, Patricia ;
Viqueira Gonzalez, Monserrat ;
Jimenez Sanchez, Roberto ;
Hernando Holgado, Ana ;
Ortin Freire, Alejandro ;
Rebollo Acebes, Sergio ;
Albaladejo Oton, Maria Dolores .
CLINICAL BIOCHEMISTRY, 2014, 47 (7-8) :505-508
[4]  
Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1097/CCM.0B013E31827E83AF, DOI 10.1007/s00134-012-2769-8]
[5]   Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study [J].
Endo, Shigeatsu ;
Suzuki, Yasushi ;
Takahashi, Gaku ;
Shozushima, Tatsuyori ;
Ishikura, Hiroyasu ;
Murai, Akira ;
Nishida, Takeshi ;
Irie, Yuhei ;
Miura, Masanao ;
Iguchi, Hironobu ;
Fukui, Yasuo ;
Tanaka, Kimiaki ;
Nojima, Tsuyoshi ;
Okamura, Yoshikazu .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) :891-897
[6]   Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program [J].
Ferrer, Ricard ;
Martin-Loeches, Ignacio ;
Phillips, Gary ;
Osborn, Tiffany M. ;
Townsend, Sean ;
Dellinger, R. Phillip ;
Artigas, Antonio ;
Schorr, Christa ;
Levy, Mitchell M. .
CRITICAL CARE MEDICINE, 2014, 42 (08) :1749-1755
[7]   Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST [J].
Kurihara, Takashi ;
Yanagida, Atsushi ;
Yokoi, Hiroyuki ;
Koyata, Atsushi ;
Matsuya, Takeshi ;
Ogawa, Junichi ;
Okamura, Yoshikazu ;
Miyamoto, Daishi .
ANALYTICAL BIOCHEMISTRY, 2008, 375 (01) :144-146
[8]   Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population [J].
Kweon, Oh Joo ;
Choi, Jee-Hye ;
Park, Sang Kil ;
Park, Ae Ja .
JOURNAL OF CRITICAL CARE, 2014, 29 (06) :965-970
[9]   The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis [J].
Levy, Mitchell M. ;
Dellinger, R. Phillip ;
Townsend, Sean R. ;
Linde-Zwirble, Walter T. ;
Marshall, John C. ;
Bion, Julian ;
Schorr, Christa ;
Artigas, Antonio ;
Ramsay, Graham ;
Beale, Richard ;
Parker, Margaret M. ;
Gerlach, Herwig ;
Reinhart, Konrad ;
Silva, Eliezer ;
Harvey, Maurene ;
Regan, Susan ;
Angus, Derek C. .
INTENSIVE CARE MEDICINE, 2010, 36 (02) :222-231
[10]   Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department [J].
Liu, Bo ;
Chen, Yun-Xia ;
Yin, Qin ;
Zhao, Yun-Zhou ;
Li, Chun-Sheng .
CRITICAL CARE, 2013, 17 (05)